Condition
Treatment of Functional Mitral Regurgitation in Symptomatic Heart Failure Subjects
Total Trials
1
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
1 treatments under study, led by Mitraclip System
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed with results
Key Signals
1 with results
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Unknown1
Clinical Trials (1)
Research Network
Common Treatments
- Mitraclip System1
Active Sponsors
- Abbott Medical Devices1
Top Investigators
The Ohio State University Heart Center
Vanderbilt University Medical Center
MOUNT SINAI HOSPITAL
Baylor Health Care System
Related Conditions
- Mitral Regurgitation1
- Mitral Valve Regurgitation1
- Heart Failure1